CervoMed Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
CervoMed Inc. (CRVO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 42.12 million shares for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2018-05-10
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-03-31 was 42.12M shares, a 307.46% increase year-over-year.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-03-31 was 10.34M shares, a 3.41% increase year-over-year.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-12-31 was 10.34M shares, a 169.20% increase year-over-year.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-09-30 was 10.33M shares, a 365.02% increase year-over-year.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 10.23M shares, a 290.57% increase from fiscal 2015.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 2.62M shares.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2011 was 75.78M shares, a 31.35% increase from fiscal 2010.
- CervoMed Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2010 was 57.69M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | 42.12M shares 10-Q · filed 2018-05-10 | ||||
| 2017-03-31 | 10.34M shares 10-Q · filed 2018-05-10 | 10.34M shares derived: average of 2 quarters · filed 2018-05-10 | 10.34M shares derived: average of 3 quarters · filed 2018-05-10 | 33.41M shares derived: average of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | 10.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | 10.33M shares derived: average of 2 quarters · filed 2017-03-31 | 41.10M shares derived: average of 3 quarters · filed 2017-03-31 | 10.23M shares 10-K · filed 2017-03-31 | |
| 2016-09-30 | 10.33M shares 10-Q · filed 2016-11-14 | 56.48M shares derived: average of 2 quarters · filed 2016-11-14 | 10.20M shares 10-Q · filed 2016-11-14 | 31.70M shares derived: average of 4 quarters · filed 2017-05-15 | |
| 2016-06-30 | 102.63M shares 10-Q · filed 2016-08-15 | 101.29M shares 10-Q · filed 2016-08-15 | 38.82M shares derived: average of 3 quarters · filed 2017-05-15 | 29.67M shares derived: average of 4 quarters · filed 2017-05-15 | |
| 2016-03-31 | 10.00M shares 10-Q · filed 2017-05-15 | 99.96M shares 10-Q · filed 2016-05-16 | 6.92M shares derived: average of 2 quarters · filed 2017-05-15 | 5.35M shares derived: average of 3 quarters · filed 2017-05-15 | 9.54M shares derived: average of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | 3.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | 3.03M shares derived: average of 2 quarters · filed 2017-03-31 | 9.38M shares derived: average of 3 quarters · filed 2017-03-31 | 2.62M shares 10-K · filed 2017-03-31 | |
| 2015-09-30 | 2.22M shares 10-Q · filed 2016-11-14 | 12.15M shares derived: average of 2 quarters · filed 2016-11-14 | 2.21M shares 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | 22.09M shares 10-Q · filed 2016-08-15 | 22.09M shares 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | 22.09M shares 10-Q · filed 2016-05-16 | ||||
| 2011-12-31 | 75.78M shares 10-K · filed 2012-05-21 | ||||
| 2010-12-31 | 57.69M shares 10-K · filed 2012-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |